Funding for this research was provided by:
Danstar Ferment AG Lallemand (P0109958)
Received: 29 June 2020
Accepted: 24 July 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: The study protocol was approved by Human Subjects Institutional Review Board (IRB)-01 of the University of Florida (IRB201900115) and was carried out in accordance to the Declaration of Helsinki. The study is registered at clinicaltrials.gov (NCT03867591). All participants provided written informed consent. The reporting of this study adheres to the CONSORT guidelines.
: Not applicable.
: KV is employed by Lallemand Bio-Ingredients, a division of Lallemand Inc., the funder of this trial. AF, DRM, KA and WJD declare no conflict of interest.